HCV-IN-39

Modify Date: 2024-01-09 18:07:56

HCV-IN-39 Structure
HCV-IN-39 structure
Common Name HCV-IN-39
CAS Number 2087916-31-0 Molecular Weight 610.78
Density N/A Boiling Point N/A
Molecular Formula C21H26BrClN3O9P Melting Point N/A
MSDS N/A Flash Point N/A

 Use of HCV-IN-39


HCV-IN-39 (Compound 18a) is a potent hepatitis C virus (HCV) nucleoside inhibitor with EC50 values of 0.644, 0.952 and 0.154 μM against GT1a, GT1b and GT1b CES1 replicons[1].

 Names

Name HCV-IN-39

 HCV-IN-39 Biological Activity

Description HCV-IN-39 (Compound 18a) is a potent hepatitis C virus (HCV) nucleoside inhibitor with EC50 values of 0.644, 0.952 and 0.154 μM against GT1a, GT1b and GT1b CES1 replicons[1].
Related Catalog
Target

EC50: 0.644 μM (GT1a), 0.952 μM (GT1b), 0.154 μM (GT1b CES1)[1]

References

[1]. Chris Krueger A, et al. Synthesis and evaluation of 2'-dihalo ribonucleotide prodrugs with activity against hepatitis C virus. Bioorg Med Chem. 2020 Jan 1;28(1):115208.

 Chemical & Physical Properties

Molecular Formula C21H26BrClN3O9P
Molecular Weight 610.78